Treatment with SGLT2 Inhibitors in Patients with Diabetes Mellitus and Extensive Coronary Artery Disease: Mortality and Cardiovascular Outcomes

INTRODUCTION: Sodium-glucose type 2 cotransporter inhibitors (SGLT2-I) have shown solid benefits in reducing cardiovascular mortality and admissions for heart failure in patients with type 2 diabetes mellitus (T2DM) and cardiovascular disease. However, no specific studies exist in patients with high...

Descripción completa

Detalles Bibliográficos
Autores principales: Chipayo-Gonzales, David, Shabbir, Asad, Vergara-Uzcategui, Carlos, Nombela-Franco, Luis, Jimenez-Quevedo, Pilar, Gonzalo, Nieves, Nuñez-Gil, Ivan, Mejia-Renteria, Hernan, Macaya-Ten, Fernando, Tirado-Conte, Gabriela, Perez-Vizcayno, Maria Jose, Fuentes, Manuel, Escaned, Javier, Fernandez-Ortiz, Antonio, Salinas, Pablo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Healthcare 2023
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570247/
https://www.ncbi.nlm.nih.gov/pubmed/37665429
http://dx.doi.org/10.1007/s13300-023-01454-w

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10570247/
https://www.ncbi.nlm.nih.gov/pubmed/37665429
http://dx.doi.org/10.1007/s13300-023-01454-w

Ejemplares similares